Live intraday price
Compare with our price levels
Close 2026-09-30: $45.43 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)
Price pulled back into the buy zone (E1) · Held by 3 whales
🎯 Trade plan by price level
Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks
Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated
Risk : reward 1 : 3.8Moves ~$2.37 a day
⚖️ Positives and risks
- ●ราคาย่อมาแตะจุดเข้า E1 (แนวรับ)
- ●แข็งแกร่งกว่าตลาด (S&P 500) +20% ใน 6 เดือน
- ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 58.42 (upside +29%, 12 ราย)
- ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
- ●รายได้โต +16% เทียบปีก่อน
- ●เซียนขายออก/ลดสัดส่วน 3 ราย: Bridgewater (ลด), Joel Greenblatt (ลด), Cathie Wood (ลด)
🕯️ Price chart
Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold
🐋 Whales holding this stock
From each whale's latest quarterly filing
👔 Insider buying & selling
Latest trades from SEC Form 4 filings
Leite John · Officer
2026-09-21 · 4,015 shares @ $40.00 · pre-planned sale (10b5-1)
Holstein Jens · Director
2026-09-14 · 5,000 shares @ $40.95 · pre-planned sale (10b5-1)
Febbo Phillip G. · Officer
2026-09-04 · 10,405 shares @ $42.89 · pre-planned sale (10b5-1)
Febbo Phillip G. · Officer
2026-09-04 · 2,705 shares @ $43.66 · pre-planned sale (10b5-1)
Chambers Rebecca · CFO
2026-09-04 · 2,477 shares @ $42.81 · pre-planned sale (10b5-1)
McGuire Annie · Officer
2026-09-04 · 2,154 shares @ $42.79 · pre-planned sale (10b5-1)
Chambers Rebecca · CFO
2026-09-04 · 1,175 shares @ $43.71 · pre-planned sale (10b5-1)
McGuire Annie · Officer
2026-09-04 · 1,100 shares @ $43.67 · pre-planned sale (10b5-1)
Bhanji Muna · Director
2026-09-01 · 1,864 shares @ $42.97 · pre-planned sale (10b5-1)
EASTHAM KARIN · Director
2026-06-18 · 3,200 shares @ $52.78 · pre-planned sale (10b5-1)
EASTHAM KARIN · Director
2026-06-18 · 529 shares @ $53.55 · pre-planned sale (10b5-1)
Stapley Marc · CEO · Director
2026-06-04 · 138,051 shares @ $50.12 · pre-planned sale (10b5-1)
Leite John · Officer
2026-06-04 · 13,975 shares @ $50.07 · pre-planned sale (10b5-1)
Chambers Rebecca · CFO
2026-06-04 · 1,961 shares @ $50.09 · pre-planned sale (10b5-1)
McGuire Annie · Officer
2026-06-04 · 1,776 shares @ $50.12 · pre-planned sale (10b5-1)
💬 User reviews
Rate and review this stock (sign-in required) — reviews don't affect the system's scores
Loading…
Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person
📰 Latest news
Cathie Wood Makes $64 Million Bet on Two Stocks
GuruFocus.com · 2026-09-28
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
Stocktwits · 2026-09-22
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Zacks · 2026-09-10
Is it Worth Adding Veracyte Stock to Your Portfolio Now?
Zacks · 2026-08-26
Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround
Zacks · 2026-08-17
🔬 Deep dive
For those who want the detailed numbers